Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Light

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Psychopharmacology|February 8, 2022
Amphetamine alters an EEG marker of reward processing in humans and miceJames F Cavanagh, Sarah L Olguin, Jo A Talledo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M<sub>1</sub> receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's diseasePradeep J Nathan, S Babli Millais, Alex Godwood, et al.
Schizophrenia Research|July 30, 2018
Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential careMichael L Thomas, Andrew W Bismark, Yash B Joshi, et al.
Trials|June 5, 2024
Enhancing patient-clinician collaboration during treatment decision-making: study protocol for a community-engaged, mixed method hybrid type 1 trial of collaborative decision skills training (CDST) for veterans with psychosisEmily B H Treichler, Lauren E McBride, Elissa Gomez, et al.
Biological Psychiatry|March 2, 2026
Visual P300 and risk for psychosis onset in youth at clinical high-riskHolly K Hamilton, Brian J Roach, Spero Nicholas, et al.
Clinical EEG and Neuroscience|November 18, 2024
Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol, Inflammation, and Gray Matter Volume in Youth at Clinical High Risk for PsychosisHolly K Hamilton, Brian J Roach, Peter M Bachman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 7, 2020
Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects studyBrian J Roach, Ricardo E Carrión, Holly K Hamilton, et al.
Biological Psychiatry Global Open Science|February 6, 2026
Theta Oscillations Assessed From a Passive Auditory Oddball Paradigm in Individuals at Clinical High-Risk for Psychosis and Healthy Control Individuals: Associations with Clinical Outcomes and Mismatch NegativityJessica P Y Hua, Brian J Roach, Holly K Hamilton, et al.
Schizophrenia Research|May 3, 2016
Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family studySteven P Millard, Jane Shofer, David Braff, et al.
JAMA Psychiatry|June 8, 2022
Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for PsychosisHolly K Hamilton, Brian J Roach, Peter M Bachman, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Psychopharmacology|February 8, 2022
Amphetamine alters an EEG marker of reward processing in humans and miceJames F Cavanagh, Sarah L Olguin, Jo A Talledo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M<sub>1</sub> receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's diseasePradeep J Nathan, S Babli Millais, Alex Godwood, et al.
Schizophrenia Research|July 30, 2018
Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential careMichael L Thomas, Andrew W Bismark, Yash B Joshi, et al.
Trials|June 5, 2024
Enhancing patient-clinician collaboration during treatment decision-making: study protocol for a community-engaged, mixed method hybrid type 1 trial of collaborative decision skills training (CDST) for veterans with psychosisEmily B H Treichler, Lauren E McBride, Elissa Gomez, et al.
Biological Psychiatry|March 2, 2026
Visual P300 and risk for psychosis onset in youth at clinical high-riskHolly K Hamilton, Brian J Roach, Spero Nicholas, et al.
Clinical EEG and Neuroscience|November 18, 2024
Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol, Inflammation, and Gray Matter Volume in Youth at Clinical High Risk for PsychosisHolly K Hamilton, Brian J Roach, Peter M Bachman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 7, 2020
Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects studyBrian J Roach, Ricardo E Carrión, Holly K Hamilton, et al.
Biological Psychiatry Global Open Science|February 6, 2026
Theta Oscillations Assessed From a Passive Auditory Oddball Paradigm in Individuals at Clinical High-Risk for Psychosis and Healthy Control Individuals: Associations with Clinical Outcomes and Mismatch NegativityJessica P Y Hua, Brian J Roach, Holly K Hamilton, et al.
Schizophrenia Research|May 3, 2016
Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family studySteven P Millard, Jane Shofer, David Braff, et al.
JAMA Psychiatry|June 8, 2022
Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for PsychosisHolly K Hamilton, Brian J Roach, Peter M Bachman, et al.
Pageof 18